Labarai

Moderna ya bayyana cewa ya kammala cikakkiyar amincewar FDA don maganin rigakafinta na COVID, wanda ake siyar dashi azaman Spikevax a ƙasashen waje.
Idan ba a manta ba, Pfizer da BioNTech sun bayyana cewa za su gabatar da sauran bayanan kafin karshen wannan karshen mako don amincewa da allurar kara karfin COVID.
Da yake magana game da masu haɓakawa, kashi na uku na rigakafin mRNA COVID-19 na iya farawa watanni 6 bayan kashi na ƙarshe maimakon watanni 8 da aka sanar a baya. (Jarida ta Wall Street)
Sabuwar gwamnan jihar New York Kathy Hochul (D) ta bayyana cewa a hukumance jihar za ta ba da sanarwar mutuwar kusan mutane 12,000 na COVID-12 da magabata ba ta kirga ba, amma an riga an shigar da waɗannan lambobin a cikin kididdigar CDC, kuma mai bin diddigin shine kamar haka. Nuna. (Associated Press)
Ya zuwa karfe 8 na safiyar ranar Alhamis, adadin wadanda suka mutu na COVID-19 da ba a hukumance ba a Amurka ya kai 38,225,849 da mutuwar 632,283, karuwar 148,326 da 1,445 bi da bi daga wannan lokaci jiya.
Adadin wadanda suka mutu ya hada da wata ma’aikaciyar jinya mai shekaru 32 da ba ta yi allurar rigakafi ba a Alabama wacce ta mutu bayan an kwantar da ita a asibiti tare da COVID-19 a farkon wannan watan; Dan cikinta ma ya rasu. (Labaran NBC)
Bayan karuwar lamura a Texas, Kungiyar Rifle ta Kasa ta soke taronta na shekara-shekara a Houston a farkon Satumba. (Labaran NBC)
Ka'idodin NIH da aka sabunta don COVID-19 mai tsanani yanzu sun ce ana iya amfani da sarilumab (Kevzara) da tofacitinib (Xeljanz) na ciki tare da dexamethasone, bi da bi, a matsayin tocilumab (Actemra) da Baritinib (Olumiant) Alternatives, idan ɗayansu ba haka bane. samuwa.
A sa'i daya kuma, hukumar ta kuma gudanar da bikin yankan kintinkiri ga sabon ofishinta na kudu maso gabashin Asiya a Vietnam.
Ascendis Pharma ya sanar da cewa a cikin jerin labarai na FDA, an amince da dogon lokaci na prodrug na girma hormone-lonapegsomatropin (Skytrofa) a matsayin magani na farko na mako-mako na rashin ci gaban hormone girma a cikin yara masu shekaru 1 da haihuwa.
Sabis Pharmaceuticals ya bayyana cewa za a iya amfani da ivosidenib (Tibsovo) azaman magani na layi na biyu ga manya tare da maye gurbin IDH1 a cikin cholangiocarcinoma na ci gaba.
FDA ta sanya wani nau'i na Class I don tunawa da wasu famfunan jiko na BD Alaris da aka gyara saboda karyewa ko keɓaɓɓen matsayi a cikin na'urar na iya haifar da katsewa, ƙarƙashin bayarwa, ko isar da ruwa ga majiyyaci.
Sun ce a duba N95 din ku don tabbatar da cewa ba Shanghai Dasheng ce ta kera su ba, saboda abin rufe fuska na kamfanin ba a ba da izinin amfani da shi ba saboda rashin kula da inganci.
Kuna so ku burge magoya bayan ku akan kafofin watsa labarun tare da Kalubalen Akwatin Milk? Kada ku yi haka, wani likitan filastik na Atlanta ya ce ya yi gargadin cewa hakan na iya haifar da rauni na tsawon rai. (Labaran NBC)
Dangane da lafiyar kwakwalwa, Shugaba Biden ya rattaba hannu kan wata doka don ba da damar tsoffin sojoji da ke fama da matsalar damuwa don horar da karnukan sabis. (Tauraron tauraro na soja da hamma)
Sabbin bayanan CDC sun nuna cewa sama da kashi 60% na al'ummar Amurka da suka cancanci an yi musu cikakken rigakafin cutar COVID. Anan ga yadda tsarin kiwon lafiya zai iya bin diddigin wadanda suka tsallake rijiya da baya a yakin neman rigakafin. (kididdiga)
Tsarin Kiwon Lafiya na Geisinger da ke Pennsylvania ya bayyana cewa a matsayin yanayin aiki, za ta buƙaci duk ma'aikatanta da a yi musu allurar rigakafin COVID-19 a tsakiyar Oktoba.
A sa'i daya kuma, layin Delta Air Lines zai biya tarar dala 200 a duk wata ga ma'aikatan da ba su yi allurar ba don kara yawan allurar. (Hanyar Bloomberg)
Tallace-tallacen kan layi da aka yi niyya ga masu ra'ayin mazan jiya sun nuna cewa rigakafin COVID "sojojin Amurka ne suka amince da su" kuma "harbi ne don dawo da 'yancinmu." (Houston Chronicle)
Abubuwan da ke wannan gidan yanar gizon don tunani ne kawai kuma ba madadin shawarwarin likita ba, ganewar asali ko jiyya da kwararrun ma'aikatan kiwon lafiya suka bayar. © 2021 MedPage Yau, LLC. duk haƙƙin mallaka. Medpage Yau yana ɗaya daga cikin alamun kasuwanci na tarayya mai rijista na MedPage A Yau, LLC kuma maiyuwa ba za a yi amfani da shi ta wasu kamfanoni ba tare da izini na musamman ba.